EP1549607A2 - Verfahren zur diastereoselektiven darstellung von olefinen durch horner-wadsworth-emmons reaktion unter verwendung von tris-(polyoxyalkyl)-aminen als sequestriermittel - Google Patents
Verfahren zur diastereoselektiven darstellung von olefinen durch horner-wadsworth-emmons reaktion unter verwendung von tris-(polyoxyalkyl)-aminen als sequestriermittelInfo
- Publication number
- EP1549607A2 EP1549607A2 EP03772375A EP03772375A EP1549607A2 EP 1549607 A2 EP1549607 A2 EP 1549607A2 EP 03772375 A EP03772375 A EP 03772375A EP 03772375 A EP03772375 A EP 03772375A EP 1549607 A2 EP1549607 A2 EP 1549607A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- radical
- chosen
- carbon atoms
- saturated
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000003352 sequestering agent Substances 0.000 title claims abstract description 23
- 150000001336 alkenes Chemical class 0.000 title claims abstract description 15
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 title abstract description 4
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims abstract description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 18
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims abstract description 8
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 7
- -1 aliphatic radical Chemical class 0.000 claims description 28
- 150000003254 radicals Chemical class 0.000 claims description 26
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 23
- 125000005842 heteroatom Chemical group 0.000 claims description 23
- 229920006395 saturated elastomer Polymers 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000002585 base Substances 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 11
- 125000004122 cyclic group Chemical group 0.000 claims description 10
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 claims description 10
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims description 8
- 150000001340 alkali metals Chemical class 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 7
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims description 6
- 125000002950 monocyclic group Chemical group 0.000 claims description 6
- 125000003367 polycyclic group Chemical group 0.000 claims description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 claims description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Chemical compound [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000012429 reaction media Substances 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 150000001343 alkyl silanes Chemical class 0.000 claims description 2
- 229910052788 barium Inorganic materials 0.000 claims description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052792 caesium Inorganic materials 0.000 claims description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 150000004679 hydroxides Chemical class 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 150000001299 aldehydes Chemical class 0.000 description 16
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 16
- XGLVDUUYFKXKPL-UHFFFAOYSA-N 2-(2-methoxyethoxy)-n,n-bis[2-(2-methoxyethoxy)ethyl]ethanamine Chemical compound COCCOCCN(CCOCCOC)CCOCCOC XGLVDUUYFKXKPL-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 8
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- KVFDZFBHBWTVID-UHFFFAOYSA-N cyclohexanecarbaldehyde Chemical compound O=CC1CCCCC1 KVFDZFBHBWTVID-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 150000003934 aromatic aldehydes Chemical class 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YUDRVAHLXDBKSR-UHFFFAOYSA-N [CH]1CCCCC1 Chemical compound [CH]1CCCCC1 YUDRVAHLXDBKSR-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 150000001728 carbonyl compounds Chemical class 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FYJKEHKQUPSJDH-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;potassium Chemical compound [K].C[Si](C)(C)N[Si](C)(C)C FYJKEHKQUPSJDH-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/48—Aldehydo radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- the present invention relates to a process for the diastereoselective preparation of olefins by the Horner-Wadsworth-Emmons reaction consisting in reacting at low temperature a phosphonate on a carbonyl derivative in the presence of a base in an appropriate solvent.
- the reaction involved is as follows:
- the carbonyl compound (B) may be an aldehyde or a ketone, with the condition that R has priority over Rio according to the rules of Cahn Ingold and Prelog. The latter are described for example in the book entitled “Advanced Organic Chemistry” Reactions, Mechanisms, and Structure, third edition, Jerry March, John Wiley & sons, 1985, the content of pages 96 to 112 of which is incorporated by reference. It is known from Tetrahedron Letters, Vol. 24, No.
- this crown ether has the disadvantage of being expensive, toxic and harmful to the environment. There was a need to find another way to improve the diastereoselectivity of the olefin obtained without using this crown ether.
- the subject of the present invention is a process for the diastereoselective preparation of olefins (C) by the Horner-Wadsworth-Emmons reaction consisting in reacting at low temperature a phosphonate (A) on a carbonyl derivative (B) in the presence a base in an appropriate solvent,
- Y represents an electron-withdrawing group known to those skilled in the art and chosen so as not to disturb the Homer-Wadsworth-Emmons reaction.
- these groups there may be mentioned in particular: -CO 2 R
- R 6 , R taken independently may be the same or different and represent: - a saturated or unsaturated, linear or aliphatic radical branched, having from 1 to 24 carbon atoms optionally substituted by heteroatoms; - a saturated, unsaturated or aromatic, monocyclic or polycyclic cycloaliphatic radical having from 4 to 24 carbon atoms optionally substituted by heteroatoms; - a saturated or unsaturated, linear or branched aliphatic radical, carrying a cyclic substituent optionally substituted by heteroatoms in the aliphatic part and / or the cyclic part;
- Rio, R and R 'taken independently may be the same or different and represent: - a hydrogen atom; a saturated or unsaturated, linear or branched aliphatic radical having from 1 to 24 carbon atoms optionally substituted by heteroatoms;
- R ⁇ , R 7 , R and R ' can also be taken together to form a saturated, unsaturated or aromatic ring optionally comprising heteroatoms;
- R 8 represents a radical chosen from:
- R 9 represents a radical chosen from:
- - a saturated, unsaturated or aromatic, monocyclic or polycyclic cycloaliphatic radical having from 4 to 24 carbon atoms optionally substituted by heteroatoms; the heteroatoms may also be present in the cyclic part; - a saturated or unsaturated, linear or branched aliphatic radical, carrying a cyclic substituent optionally substituted by heteroatoms in the aliphatic part and / or the cyclic part; with the condition that R has priority over Rio according to the rules of Cahn Ingold and Prelog,
- n is an integer between 0 and 10;
- Ri, R 2 , R 3 , R 4 may be the same or different, and represent a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms;
- R 5 represents a hydrogen atom, an alkyl or cycloalkyl radical having up to 12 carbon atoms, a phenyl radical or a radical of formula -C m H 2m - ⁇ , or
- a tris- (polyoxaalkyl) -amine sequestering agent of formula (I) is used in which:
- Ri, R 2 , R 3 , Ri may be the same or different, and represent a hydrogen atom or a methyl radical; n is an integer between 0 and 3;
- R 5 represents a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms.
- a tris- (polyoxaalkyl) -amine sequestering agent of formula (I) is used in which: Ri, R 2 , R 3 , R 4 represent a hydrogen atom; n is 1;
- R 5 represents a methyl radical.
- the tris- (polyoxaalkyl) -amine sequestering agent of formula (I) can be used in an amount which varies from 0.05 to 10 equivalents per 1 equivalent of phosphonate, one equivalent of aldehyde and one equivalent of base.
- the amount of tris- (polyoxaalkyl) -amine sequestering agent of formula (I) used is from 0.1 to 5 equivalents per 1 equivalent of phosphonate, one equivalent of aldehyde and one equivalent of base.
- the amount of tris- (polyoxaalkyl) -amine sequestering agent of formula (I) used is 1 equivalent for 1 equivalent of phosphonate, one equivalent of aldehyde and one equivalent of base, the whole being put in solution in a solvent.
- the phosphonate used for the reaction can be chosen from the phosphonates of formula (A): in which,
- Y represents CO 2 R, with R represents a hydrogen atom, an alkyl radical having from 1 to 12 linear, branched or cyclic, saturated or unsaturated carbon atoms, R e and R 7 represent a radical -CH 2 CF 3 , and R 8 represents a hydrogen atom.
- R represents a hydrogen atom, an alkyl radical having from 1 to 12 linear, branched or cyclic, saturated or unsaturated carbon atoms
- R e and R 7 represent a radical -CH 2 CF 3
- R 8 represents a hydrogen atom.
- a phosphonate of formula (A) is used in which:
- Y represents a CO 2 R radical, and R represents a methyl radical
- R 6 and R 7 represent a radical -CH 2 CF 3 ; and R 8 represents a hydrogen atom.
- the carbonyl derivative (B) used for the reaction can be an aldehyde or a ketone.
- the substituents R 9 and Rio are of course chosen so as not to disturb the Homer-Wadsworth-Emmons reaction.
- a condition according to the rule of Cahn, Ingold and Prélog was imposed, so as to define the selectivity of the olefin (C).
- the rule of Cahn Ingold and Prélog is described for example in the book entitled "Advanced Organic Chemistry” Reactions, Mechanisms, and Structure, third edition, Jerry March, John Wiley & sons, 1985 whose content of pages 96 to 112 is incorporated by reference.
- the carbonyl derivative (B) is preferably chosen from aldehydes, which corresponds to Rio representing a hydrogen atom.
- the aldehydes used can be, depending on the nature of the radical R 9 , aliphatic, and optionally include ethylenic unsaturations, or they can be aromatic. In the case where the aldehydes used are aromatic, they can comprise possible substitutions by electron-donating or electron-withdrawing groups.
- the electron donor group mention may be made of C1-C6 alkyl and C1- alkoxy groups.
- electron withdrawing group is understood to mean a group as defined by HC BROWN in the book entitled “Advanced Organic Chemistry” Reactions, Mechanisms, and Structure, third edition, Jerry March, John Wiley & sons, 1985, the contents of pages 243 and 244 are incorporated by reference. Mention may in particular be made, as representative of the electron-withdrawing groups:
- aromatic aldehyde is used.
- aliphatic aldehydes mention may be made of cyclohexane carboxaldehyde (R 9 is a cyclohexyl radical) or an aliphatic aldehyde in which R 9 is nC 7 H ⁇ s. It is preferred to use the aliphatic aldehyde in which R 9 is a cyclohexyl radical.
- aromatic aldehydes there may be mentioned benzaldehyde (R represents a phenyl radical), or an aldehyde characterized in that the radical R 9 used is aromatic and optionally comprises one or more substitutions by alkoxy groups having from 1 to 6 carbon atoms or halogen atoms. Mention may also be made, by way of example, of the aldehydes listed in the table VIL
- aromatic aldehyde can include heteroatoms in the aromatic ring.
- the aromatic aldehyde can also include substitutions by CF 3 groups.
- the base is chosen from: - amides of the MNR “R” 'type with M an alkali metal such as lithium, sodium or potassium, and R ", R'” being chosen from alkyl radicals or radicals of the type alkylsilane, such as the potassium salt of hexamethyldisilazane (KHMDS),
- alkali or alkaline earth hydroxides such as LiOH, NaOH, KOH, CsOH, Mg (OH) 2 , Ca (OH) 2 , Ba (OH) 2 ,
- organic bases such as l, 8-diazabicyclo [5.4.0] undec-7-ene (DBU), l, l, 3,3-tetramethylguanidine (TMG), or l, 4-diazabicyclo [2.2 .2] octane (DABCO) in combination with alkali or alkaline earth halides.
- DBU 8-diazabicyclo [5.4.0] undec-7-ene
- TMG 3,3-tetramethylguanidine
- DABCO 4-diazabicyclo [2.2 .2] octane
- the potassium salt of hexamethyldisilazane (KHMDS) or potassium tert-butoxide (tBuOK) is used.
- the solvent used is an organic solvent.
- a polar solvent is used.
- an ethereal solvent such as THF or mefhylterbutylether (MTBE) is used.
- the amount of solvent used is generally between 0.1 and 20 ml per mmol of phosphonate.
- the improvement in the selectivity of the reaction in the presence of the sequestering agent of the invention is observed whatever the temperature. It is thus possible to implement the method of the invention at a temperature of 0 ° C. However, it is preferred to carry out the process of the invention at a temperature less than or equal to -20 ° C, and even more preferably at a temperature less than or equal to -50 ° C. As an indication, the reaction is generally carried out at a temperature above -100 ° C.
- Example 1 Demonstration of the Effect of the TDA-1 Sequestering Agent and Comparison with the 18-crown- ⁇ at -78 ° C
- the phosphonate used corresponds to a phosphonate of formula (A) in which:
- Y represents a CO R radical with R representing a methyl radical, R 6 and R 7 represent a -CH 2 CF 3 radical; and R 8 represents a hydrogen atom.
- the carbonyl compound (B) used is benzaldehyde.
- the base used is potassium hexamethyldisilazane (KHMDS) dissolved in toluene at 0.5M.
- KHMDS potassium hexamethyldisilazane
- the solvent used is THF.
- TDA-1 The sequestering agent of the invention used, called TDA-1, corresponds to a tris- (polyoxaalkyl) -amine sequestering agent of formula (I) in which:
- Ri, R 2 , R 3 , R 4 represent a hydrogen atom; n is 1;
- R 5 represents a methyl radical
- the mixture is analyzed by gas chromatography using a Narian Star 3400CX device.
- the column used is a DB1 125-1034 from J&W Scientific (length: 30 m, internal diameter: 0.53 mm and film thickness of 3 ⁇ m).
- the initial temperature of the column is 100 ° C and the temperature rise of 7 ° C per minute. Under these conditions, the retention times of the various compounds are as follows:
- the Z and E isomers are defined in the reaction scheme boxed on the previous page. In the present case, the role of the additive is to improve the selectivity for the Z isomer.
- TDA-1 sequestering agent of the invention
- Example 2 Evaluation of the conditions of Example 1 (THF, KHMDS, TDA-1, -78 ° C) with cyclohexanecarboxaldehyde
- Example 2 the procedure of Example 1 is repeated and the nature of the aldehyde used is varied. Benzaldehyde is replaced by cyclohexanecarboxaldehyde (R 9 represents a cyclohexyl radical). The temperature is maintained for approximately 4 hours at -78 ° C. before allowing the system to return to ambient temperature overnight. The reaction medium is then treated by the addition of a saturated solution of ammonium chloride and extracted with toluene.
- R 9 represents a cyclohexyl radical
- Example 1 the mixture is analyzed by gas chromatography using a Varian Star 3400CX device.
- the column used is a DB1 125-1034 from J&W Scientific (length: 30 m, internal diameter: 0.53 mm and film thickness of 3 ⁇ m).
- the initial temperature of the column is 100 ° C and the temperature rise of 7 ° C per minute.
- the retention times (Î R ) of the various compounds are as follows:
- Example 3 Effect of the concentration under the conditions of Example 1 (THF, KHMDS TDA-1, -78 ° C benzaldehyde)
- Example 1 The procedure of Example 1 is repeated with TDA-1 and several tests are carried out by reducing the amount of THF used.
- the tests are carried out with respectively 20 ml of THF (volume of Example 1), 4 ml of THF, 2 ml of THF and without THF. This corresponds to phosphonate concentrations of 0.05M, 0.15M, 0.21M and 0.41M.
- Table IV The results obtained are shown in Table IV below.
- the toluene in the KHMDS solution is the reaction solvent.
- the transformation is much slower and much less selective.
- Example 4 Use of potassium tert-butoxide as a base under the conditions of Example 1 (THF, TDA-1, -78 ° C)
- the temperature is maintained for approximately 4 hours at -78 ° C. before allowing the system to return to ambient temperature overnight.
- the reaction medium is then treated by the addition of a saturated solution of ammonium chloride and extracted with toluene. The results will be collated in the table below.
- Example 5 Effect of the concentration under the conditions of Example 4 (Benzaldehyde HF, tBuOK, TDA-1, -78 ° C)
- Example 4 The procedure of Example 4 is repeated with benzaldehyde and several tests are carried out by reducing the amount of THF used. The tests are carried out with 20 ml of THF respectively (volume of Example 4), 4 ml of THF, 2 ml of THF and 1 ml of THF. This corresponds to phosphonate concentrations of 0.05M, 0.21M, 0.37M and 0.60M. The results obtained are shown in Table VI below.
- the medium is allowed to rise to ambient temperature overnight before treatment.
- MTBE methyl tert-butyl ether
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0211731 | 2002-09-23 | ||
| FR0211731A FR2844791B1 (fr) | 2002-09-23 | 2002-09-23 | Procede de preparation diastereoselectif d'olefines par la reaction d'horner-wadsworth-emmons comprenant un ajout d'un agent sequestrant tris-(polyoxaalkyl)-amine |
| PCT/FR2003/002781 WO2004026806A2 (fr) | 2002-09-23 | 2003-09-22 | Procede de preparation diastereoselectif d'olefines par la reaction d'horner-wadsworth-emmons comprenant un ajout d'un agent sequestrant tris-(polyoxaalkyl)-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1549607A2 true EP1549607A2 (de) | 2005-07-06 |
Family
ID=31970894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03772375A Withdrawn EP1549607A2 (de) | 2002-09-23 | 2003-09-22 | Verfahren zur diastereoselektiven darstellung von olefinen durch horner-wadsworth-emmons reaktion unter verwendung von tris-(polyoxyalkyl)-aminen als sequestriermittel |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060100456A1 (de) |
| EP (1) | EP1549607A2 (de) |
| CN (1) | CN100378059C (de) |
| AU (1) | AU2003279429A1 (de) |
| CA (1) | CA2499635A1 (de) |
| FR (1) | FR2844791B1 (de) |
| WO (1) | WO2004026806A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2519100T3 (pl) | 2009-12-29 | 2017-09-29 | Mapi Pharma Limited | Związki pośrednie i sposoby wytwarzania tapentadolu i pokrewnych związków |
| CN103102256A (zh) * | 2013-01-24 | 2013-05-15 | 复旦大学 | 一种光学活性7-取代氧基-6-羟基庚-3-乙烯-2-酮的制备方法 |
| CN103145540B (zh) * | 2013-03-17 | 2015-07-29 | 复旦大学 | 一种光学活性7-卤代-6-羟基-庚-3-烯-2-酮的制备方法 |
| CN105152973B (zh) * | 2015-08-20 | 2017-04-12 | 浙江工业大学 | 一种二苯乙烯衍生物及其制备方法和应用 |
| CN106674255B (zh) * | 2016-12-21 | 2018-11-13 | 南京工业大学 | 致电变色化合物单体bedot-v-p及合成和应用 |
| CN109438357A (zh) * | 2018-11-05 | 2019-03-08 | 重庆科脉生物化工有限公司 | 一种咪唑类医药中间体kk-42的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10203122A1 (de) * | 2002-01-25 | 2003-07-31 | Gruenenthal Gmbh | Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren |
-
2002
- 2002-09-23 FR FR0211731A patent/FR2844791B1/fr not_active Expired - Fee Related
-
2003
- 2003-09-22 WO PCT/FR2003/002781 patent/WO2004026806A2/fr not_active Ceased
- 2003-09-22 EP EP03772375A patent/EP1549607A2/de not_active Withdrawn
- 2003-09-22 AU AU2003279429A patent/AU2003279429A1/en not_active Abandoned
- 2003-09-22 CN CNB038226383A patent/CN100378059C/zh not_active Expired - Fee Related
- 2003-09-22 CA CA002499635A patent/CA2499635A1/fr not_active Abandoned
- 2003-09-22 US US10/528,715 patent/US20060100456A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004026806A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004026806A2 (fr) | 2004-04-01 |
| US20060100456A1 (en) | 2006-05-11 |
| CA2499635A1 (fr) | 2004-04-01 |
| CN1684939A (zh) | 2005-10-19 |
| CN100378059C (zh) | 2008-04-02 |
| AU2003279429A8 (en) | 2004-04-08 |
| FR2844791A1 (fr) | 2004-03-26 |
| FR2844791B1 (fr) | 2004-10-29 |
| WO2004026806A3 (fr) | 2004-04-22 |
| AU2003279429A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1144346B1 (de) | Verfahren zur herstellung von beta-phosphorierten nitroxid-radikalen | |
| EP0680968A1 (de) | Verfahren zur Herstellung von Ginkgolide B aus Ginkgolide C | |
| EP1549607A2 (de) | Verfahren zur diastereoselektiven darstellung von olefinen durch horner-wadsworth-emmons reaktion unter verwendung von tris-(polyoxyalkyl)-aminen als sequestriermittel | |
| EP1349862B1 (de) | VERFAHREN ZUR HERSTELLUNG VON Beta-PHOSPHORNITROXIDRADIKALEN | |
| CA2543880A1 (fr) | Procede diastereoselectif de preparation d'olefines par la reaction d'horner-wadsworth-emmons mettant en oeuvre un phosphonate particulier qui ameliore la diastereoselectivite a toutes temperatures y compris a temperature ambiante | |
| CA1038880A (fr) | Procede de preparation d'esters d'acide chrysanthemique | |
| EP3592753B1 (de) | Neuartige zusammensetzung von 7,9-dodecadienyl-1-acetat-isomeren und verfahren zur herstellung davon | |
| EP0100717B1 (de) | Verfahren zur Herstellung von alpha-Alkylamino-Aldehyden | |
| CA1087614A (fr) | Procede de preparation de la prostaglandine a.sub.2 et de certains de ses derives | |
| EP0127536B1 (de) | Verfahren zur Herstellung von alpha-delta-diethylenischen Carbonylverbindungen | |
| FR2479192A1 (fr) | Procede de preparation de derives cyclopropaniques tetra-substitues | |
| EP0187631B1 (de) | Verfahren zur Herstellung von Pyrrolopyridinderivaten und so erhaltene Derivate | |
| FR2909671A1 (fr) | Procede de preparation de composes 1,3,2-oxazaborolidines | |
| EP0060767B1 (de) | Verfahren zur Herstellung von delta-äthylenisch ungesättigten Carbonylverbindungen | |
| FR2738825A1 (fr) | Procede de purification d'un 1,3-bis(3-aminopropyl)-1,1, 3,3-tetraorgano-disiloxane | |
| WO2016016414A1 (fr) | Procédé de création de liaisons carbone-carbone, non catalysé, à partir de composés carbonylés | |
| EP0069010B1 (de) | Verfahren zur Herstellung von delta-Äthylenischen Carbonylverbindungen | |
| EP0374014A2 (de) | Organomanganverbindungen, ihre Herstellung und ihre Verwendung | |
| WO2001002321A1 (fr) | Procede de substitution nucleophile | |
| EP0082782A1 (de) | Verfahren zur Herstellung von ethylenischen Acetalen | |
| FR2501196A1 (fr) | Procede de preparation de composes carbonyles d-ethyleniques | |
| WO1987003597A1 (fr) | Procede de preparation de n-sulfonyl n-(phosphonomethylglycyl) amines utilisables comme herbicides | |
| CH364497A (fr) | Procédé de préparation de monoéthers de glycols | |
| EP2331492A1 (de) | Verfahren zur herstellung des ethylesters von 4-[trans-4] (phenylmethyl)amino[cyclohexyl] benzoesäure und dessen hemifumaratsalz | |
| EP0382641A1 (de) | Verfahren zur Herstellung von Ditertioalkyldicarbonat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050406 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MANFRE, FRANCO Inventor name: SCHLAMA, THIERRY Inventor name: LE GUYADER, FREDERIC Inventor name: BUISINE, OLIVIER Inventor name: TOUCHARD, FRANCOIS |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MANFRE, FRANCO Inventor name: SCHLAMA, THIERRY Inventor name: LE GUYADER, FREDERIC Inventor name: BUISINE, OLIVIER Inventor name: TOUCHARD, FRANCOIS |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100401 |